Tairawhiti District Health Board

Details

Name :

Tairawhiti District Health Board

Address  :

421 Ormond Rd, Riverdale

Town  :

Gisborne

State  :

Gisborne

Country  :

NEW ZEALAND

Post Code:

4010

Phone  :

06 8688019

Web URL  :

Specialization
  • General Surgeon
  • Gynaecology
  • Orthopedics
Facilities

Other Facilities

  • X-Ray
  • physiotherapy


Description

About Us
Tairawhiti District Health TDH is a Crown Entity that was established in 2001 and covers the area from beyond Hicks Bay in the north to the Wharerata ranges in the south

Our mission is Working together to elevate the wellbeing of Tairawhiti

Mahia nga mahi i roto i te kotahitanga kia piki ake to oranga o te Tairawhiti

As a District Health Board TDH funds and ensures the provision of services for those in need of personal health and disability services across all service areas except Public Health and Disability Support Services for people under 65 years of age

A large percentage of this work is done from the main campus on Ormond Road where Gisborne Hospital is situated

TDH has a board and three statutory advisory committees which are responsible for the overall governance and direction of the District Health Board They work within national frameworks set by the Government The role of the Board is to work to improve the health outcomes and enhance the health status of the population it serves

Primary health care services and communitybased care are delivered through providers such as Primary Health Organisations GPs Maori health providers and disability support providers that are funded by Tairawhiti District Health
Hospitals will get a shot in the arm

District health boards are snapping up a British National Health Service initiative to improve productivity in hospital wards and operating theatres The Productive Operating Theatre and Productive Wards Releasing Time to Care programmes involve relatively lowcost and simple measures Bay of Plenty District Health Board among the first to impl... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More